Medicamen Biotech Ltd (MEDICAMEQ) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 770569, "name": "Medicamen Biotec", "stock_name": "Medicamen Biotec", "full_name": "Medicamen Biotech Ltd", "name_url": "stocks-analysis/medicamen-biotec", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "250.83", "chg": 10.81, "chgp": "4.5%", "dir": 1, "prev_price": "240.02", "mcapval": "327.00 Cr", "mcap": "Micro Cap", "scripcode": 531146, "symbol": "MEDICAMEQ", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE646B01010", "curr_date": "Aug 04, 03:30 PM", "curr_time": "06:03 AM", "last_traded_at": "Aug 04, 03:30 PM IST", "bse_nse_vol": "24.36 k", "exc_status": "Active", "traded_date": "Aug 04, 2026", "traded_date_str": "2026 08 04", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medicamen-biotec-770569-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Medicamen Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-sell-4132175", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MedicamenBiotec_mojoScore_4132175.png", "date": "2026-08-02 10:10:38", "description": "Medicamen Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with the most up-to-date perspective on the company’s standing." }, { "title": "Medicamen Biotech Ltd Valuation Shifts Signal Changing Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-shifts-signal-changing-market-sentiment-4121753", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicamenBiotec_valuationdot_4121753.png", "date": "2026-07-27 08:00:58", "description": "Medicamen Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging performance track record relative to the broader market. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid the company’s micro-cap status and sector dynamics." }, { "title": "Medicamen Biotech Gains 0.52%: 2 Key Factors Driving the Week’s Mixed Moves", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-gains-052-2-key-factors-driving-the-weeks-mixed-moves-4120683", "imagepath": "", "date": "2026-07-25 16:06:12", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Jul:</strong> Valuation improves amid challenging market returns</p>\n <p><strong>22 Jul:</strong> Downgrade to Sell rating by MarketsMOJO</p>\n <p><strong>24 Jul:</strong> Week closes at Rs.242.20 (+0.52%) outperforming Sensex</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.240.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.242.20</div><div class=\"stat-change positive\">+0.52%</div></div>\n <div class=\"stat-item\"><div cla..." }, { "title": "Medicamen Biotech Downgraded to Sell Amid Mixed Financial and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-downgraded-to-sell-amid-mixed-financial-and-valuation-signals-4114614", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicamenBiotec_mojoScore_4114614.png", "date": "2026-07-22 08:13:59", "description": "Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 July 2026. Despite an upgrade in valuation metrics, the company’s overall financial trend and quality indicators have raised concerns, prompting a cautious stance from analysts. This article delves into the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change." }, { "title": "Medicamen Biotech Ltd Valuation Improves Amid Challenging Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-improves-amid-challenging-market-returns-4108398", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicamenBiotec_valuationdot_4108398.png", "date": "2026-07-20 08:00:56", "description": "Medicamen Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, signalling a positive change in price attractiveness despite ongoing headwinds in the pharmaceuticals and biotechnology sector. This upgrade reflects evolving market perceptions and improved relative metrics compared to its historical averages and peer group." }, { "title": "Medicamen Biotech Ltd Declines 1.19%: Valuation Upgrade and Mixed Financial Signals Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-declines-119-valuation-upgrade-and-mixed-financial-signals-shape-the-week-4107452", "imagepath": "", "date": "2026-07-18 15:06:02", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Stock opens at Rs.238.30, down 2.28% amid cautious sentiment</p>\n <p><strong>14 Jul:</strong> Medicamen Biotech Ltd upgraded to Hold on valuation improvement</p>\n <p><strong>15 Jul:</strong> Price rebounds 1.84% to Rs.237.40 following upgrade news</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.240.95, down 1.19% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.243.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div ..." }, { "title": "Medicamen Biotech Ltd Upgraded to Hold on Valuation Improvement and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-upgraded-to-hold-on-valuation-improvement-and-financial-trends-4100219", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicamenBiotec_mojoScore_4100219.png", "date": "2026-07-14 08:28:23", "description": "Medicamen Biotech Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by a marked improvement in valuation metrics and positive quarterly financial performance. Despite ongoing challenges in long-term growth and relative underperformance against benchmarks, the company’s enhanced valuation attractiveness and stable financial trends have prompted a reassessment of its market stance." }, { "title": "Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-shifts-signal-renewed-price-attractiveness-4099786", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicamenBiotec_valuationdot_4099786.png", "date": "2026-07-14 08:00:52", "description": "Medicamen Biotech Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing market headwinds and a challenging sector environment. This change reflects a notable improvement in price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, offering investors a fresh perspective on the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector." }, { "title": "Medicamen Biotech Downgraded to Sell Amid Mixed Financials and Valuation Shifts", "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-downgraded-to-sell-amid-mixed-financials-and-valuation-shifts-4091697", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicamenBiotec_mojoScore_4091697.png", "date": "2026-07-07 08:32:35", "description": "Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 July 2026. This change reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive quarterly financial results, the company’s long-term growth challenges and relative underperformance against benchmarks have weighed heavily on the revised outlook." } ], "total": 6261, "sid": "770569", "stock_news_url": "https://www.marketsmojo.com/news/medicamen-biotech-770569" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

20 Jul: Valuation improves amid challenging market returns

22 Jul: Downgrade to Sell rating by MarketsMOJO

24 Jul: Week closes at Rs.242.20 (+0.52%) outperforming Sensex

Read full news article

Medicamen Biotech Downgraded to Sell Amid Mixed Financial and Valuation Signals

2026-07-22 08:13:59

Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 July 2026. Despite an upgrade in valuation metrics, the company’s overall financial trend and quality indicators have raised concerns, prompting a cautious stance from analysts. This article delves into the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change.

Read full news article

Medicamen Biotech Ltd Valuation Improves Amid Challenging Market Returns

2026-07-20 08:00:56

Medicamen Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, signalling a positive change in price attractiveness despite ongoing headwinds in the pharmaceuticals and biotechnology sector. This upgrade reflects evolving market perceptions and improved relative metrics compared to its historical averages and peer group.

Read full news article

Medicamen Biotech Ltd Declines 1.19%: Valuation Upgrade and Mixed Financial Signals Shape the Week

2026-07-18 15:06:02

Key Events This Week

13 Jul: Stock opens at Rs.238.30, down 2.28% amid cautious sentiment

14 Jul: Medicamen Biotech Ltd upgraded to Hold on valuation improvement

15 Jul: Price rebounds 1.84% to Rs.237.40 following upgrade news

17 Jul: Week closes at Rs.240.95, down 1.19% for the week

Week Open

Rs.243.85

Week Close

Read full news article

Medicamen Biotech Ltd Upgraded to Hold on Valuation Improvement and Financial Trends

2026-07-14 08:28:23

Medicamen Biotech Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by a marked improvement in valuation metrics and positive quarterly financial performance. Despite ongoing challenges in long-term growth and relative underperformance against benchmarks, the company’s enhanced valuation attractiveness and stable financial trends have prompted a reassessment of its market stance.

Read full news article

Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-07-14 08:00:52

Medicamen Biotech Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing market headwinds and a challenging sector environment. This change reflects a notable improvement in price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, offering investors a fresh perspective on the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector.

Read full news article

Medicamen Biotech Downgraded to Sell Amid Mixed Financials and Valuation Shifts

2026-07-07 08:32:35

Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 July 2026. This change reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive quarterly financial results, the company’s long-term growth challenges and relative underperformance against benchmarks have weighed heavily on the revised outlook.

Read full news article

View All News